Ortin Global Limited (NSE:ORTINGLOBE)
13.06
-0.67 (-4.88%)
Apr 6, 2026, 4:19 PM IST
Ortin Global Market Cap
Ortin Global has a market cap or net worth of 106.2 million as of April 6, 2026. Its market cap has decreased by -17.60% in one year.
Market Cap
106.20M
Enterprise Value
112.32M
Revenue
1.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.06
Market Cap Chart
Since April 12, 2007, Ortin Global's market cap has increased from 48.26M to 106.20M, an increase of 120.05%. That is a compound annual growth rate of 4.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 106.20M | -8.54% |
| Dec 31, 2025 | 116.12M | -20.22% |
| Dec 31, 2024 | 145.55M | -22.24% |
| Dec 29, 2023 | 187.18M | -2.87% |
| Dec 30, 2022 | 192.71M | -27.96% |
| Dec 31, 2021 | 267.52M | -46.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sakar Healthcare | 11.47B |
| Sigachi Industries | 7.39B |
| Valiant Laboratories | 3.11B |
| Bafna Pharmaceuticals | 2.63B |
| Nectar Lifesciences | 1.95B |
| Brooks Laboratories | 1.57B |
| Alpa Laboratories | 1.09B |
| Par Drugs and Chemicals | 1.01B |